Philip Morris
Tolerance Withdrawal and Dependence on Tobacco and Smoking Termination
Fields
- Author
- Fagerstrom, K.O.
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- CHAR, CHART, GRAPH, TABLE, MAPS
- BIBL, BIBLIOGRAPHY
- Site
- N403
- Request
- Stmn/R1-036
- Stmn/R1-072
- Stmn/R1-073
- Stmn/R4-005
- Stmn/R1-072
- Author (Organization)
- Utteraker Hospital
- Master ID
- 2046398862/0490
Related Documents:- 2046398862-8874 Submission of Phillip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Iots Meeting on 940802 Volume 3.01
- 2046398875 2
- 2046398876-8886 Diagnostic and Statistical Manual of Mental Disorders Fourth Edition Dsm-IV
- 2046398887 3
- 2046398888-8892 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition - Revised) Dsm-III-R
- 2046398893 4
- 2046398894-8897 Diagnostic and Statistical Manual of Mental Disorders ( Third Edition)
- 2046398898 5
- 2046398899-8901 What Makes US Run?
- 2046398902 6
- 2046398903-8931 Chapter 5 the Neurochemical Mechanisms Underlying Nicotine Tolerance and Dependence
- 2046398932 7
- 2046398933-8994 8. The Psychopharmacological and Neurochemical Consequences of Chronic Nicotine Administration
- 2046398995 8
- 2046398997-8999 Establishing A Nicotine Threshold for Addiction
- 2046399000 9
- 2046399001-9006 Intravenous Nicotine Replacement Suppresses Nicotine Intake From Cigarette Smoking
- 2046399007 10
- 2046399008-9013 Daily Intake of Nicotine During Cigarette Smoking
- 2046399014 11
- 2046399015-9022 Stable Isotope Studies of Nicotine Kinetics and Bioavailability
- 2046399023 12
- 2046399024-9060 Biobehavioral Approaches to Smoking Control
- 2046399061 13
- 2046399062-9064 Brief Communication Preference Among Research Cigarettes with Varying Nicotine Yields
- 2046399065 14
- 2046399066-9076 Slip-Ups and Relapse in Attempts to Quit Smoking
- 2046399077 15
- 2046399078-9100 Drug Addiction As A Psychological Process
- 2046399101 16
- 2046399102-9113 Population Characteristics and Cigarette Yield As Determinants of Smoke Exposure
- 2046399114 17
- 2046399115-9123 Smoking History, Cigarette Yield and Smoking Behavior As Determinants of Smoke Exposure.
- 2046399124 Andrews Office Products Capitol Heights, Md (K) 18
- 2046399125-9216 Out of the Shadows Understanding Sexual Addiction Second Edition
- 2046399217 Andrews Office Products Capitol Heights, Md (K) 19
- 2046399218-9220 Morbidity and Mortality Weekly Report Progress in Chronic Disease Prevention Smoking Cessation During Previous Year Among Adults - United States, 900000 and 910000
- 2046399221 Andrews Office Products Capitol Heights, Md (K) 20
- 2046399222-9224 Research Report Can Carrots Be Addictive? An Extraordinary Form of Drug Dependence
- 2046399225 Andrews Office Products Capitol Heights, Md (K) 21
- 2046399226-9233 Running Addiction: Measurement and Associated Psychological Characteristic
- 2046399234 Andrews Office Products Capitol Heights, Md (K) 22
- 2046399235-9252 Goth's Medical Pharmacology
- 2046399253 Andrews Office Products Capitol Heights, Md (K)
- 2046399254-9272 An Analysis of the Addiction Liability of Nicotine
- 2046399273 Andrews Office Products Capitol Heights, Md (K) 24
- 2046399274-9283 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399284 Andrews Office Products Capitol Heights, Md (K) 25
- 2046399285-9288 the Effect of Running on Plasma Beta-Endorphin
- 2046399289
- 2046399290 Library Copy: Please Return
- 2046399291 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.02
- 2046399292 21 Andrews Office Products Capitol Heights, Md (K)
- 2046399293-9300 Running Addiction: Measurement and Associated Psychological Characteristics
- 2046399301 22 Andrews Office Products Capitol Heights, Md (K)
- 2046399302-9319 Goth's Medical Pharmacology Drug Abuse and Dependence
- 2046399320 23 Andrews Office Products Capitol Heights, Md (K)
- 2046399321-9339 An Analysis of the Addiction Liability of Nicotine
- 2046399340 24 Andrews Office Products Capitol Heights, Md (K)
- 2046399341-9350 Modulation of Nicotine Receptors by Chronic Exposure to Nicotinic Agonists and Antagonists
- 2046399351 25 Andrews Office Products Capitol Heights, Md (K)
- 2046399352-9355 the Effect of Running on Plasma B-Endorphin
- 2046399356 26 Andrews Office Products Capitol Heights, Md (K)
- 2046399357-9375 Shopaholics Serious Help for Addicted Spenders Chapter 3 Nature of Addiction
- 2046399376 27 Andrews Office Products Capitol Heights, Md (K)
- 2046399377-9380 Effect of Transdermal Nicotine Delivery As An Adjunct to Low-Intervention Smoking Cessation Theraphy
- 2046399381 28 Andrews Office Products Capitol Heights, Md (K)
- 2046399382-9394 Measuring Nicotine Dependence: A Review of the Fagerstrom Tolerance Questionnaire
- 2046399395 29
- 2046399420 30 Andrews Office Products Capitol Heights, Md (K)
- 2046399421-9426 Methods Used to Quit Smoking in the United States Do Cessation Programs Help?
- 2046399427 31 Andrews Office Products Capitol Heights, Md (K)
- 2046399428-9434 Effect of Transdermal Nicotine Patches on Cigarette Smoking A Double Blind Crossover Study
- 2046399435 32
- 2046399435A Symposium Smoking Cessation: A Comparison of Aided Vs. Unaided Quitters / Attempters. Predictors of Early Relapse.
- 2046399436 33
- 2046399437-9448 Mind Matters How Mind and Brain Interact to Create Our Conscious Lives
- 2046399449 34
- 2046399450-9452 Cigarette Craving, Smoking Withdrawal, and Clonidine
- 2046399453 35
- 2046399454-9456 Psycological and Pharmacological Influences in Cigarette Smoking Withdrawal: Effects of Nicotine Gum and Expectancy on Smoking Withdrawal Symptoms and Relapse
- 2046399457 36
- 2046399458-9463 Crs Report for Congress Cigarette Taxes to Fund Health Care Reform: An Economic Analysis
- 2046399464 37
- 2046399465-9472 22.4 Caffeine and Tobacco Dependence
- 2046399473 38
- 2046399474-9476 Pinball Wizard: the Case of A Pinball Machine Addict
- 2046399477 39
- 2046399478-9492 Reviews Caffeine Physical Dependence: Review of Human and Laboratory Animal Studies
- 2046399493 40
- 2046399494-9498 Brief Report Reactions to Withdrawal Symptoms and Success in Smoking Cessation Clinics
- 2046399499 41
- 2046399500-9505 Nicotine or Tar Titration in Cigarette Smoking Behavior?
- 2046399506 42
- 2046399507-9511 Brief Report Blood Nicotine, Smoke Exposure and Tobacco Withdrawal Symptoms
- 2046399512 43
- 2046399513-9523 Conference Report Involvement of Tobacco in Alcoholism and Illicit Drug Use
- 2046399524 44
- 2046399525-9535 Pharmacologic Basis and Treatment of Cigarette Smoking
- 2046399536 45
- 2046399537-9550 'chocolate Addiction': A Preliminary Study of Its Description and Its Relationship to Problem Eating
- 2046399551 46
- 2046399552-9562 Smoking Cessation Methods: Recommendations for Health Professionals. Advisory Group of the European School of Oncology
- 2046399563 47
- 2046399564-9574 Nicotine Yield As Determinant of Smoke Exposure Indicators and Puffing Behavior
- 2046399575 48
- 2046399576-9581 Psychological Analysis of Establishment and Maintenance of the Smoking Habit
- 2046399582 49
- 2046399583-9586 Seminars in Respiratory Medicine Appetitive Functions and Dysfunctions: Tobacco
- 2046399587 Andrews Office Products Capitol Heights, Md (K)
- 2046399588 Endorphins, Eating Disorders and Other Addictive Behaviors
- 2046399589-9621 the Clinical Phases of Anorexia Nervosa and Their Relevance to Endorphin Addiction
- 2046399622 51
- 2046399623-9632 Pharmacotheraphy for Smoking Cessation: Unvalidated Assumptions, Anomalies, and Suggestions for Future Research
- 2046399633 52
- 2046399634-9641 Risk - Benefit Assessment of Nicotine Preparations in Smoking Cessation
- 2046399642 53
- 2046399643-9650 Should Caffeine Abuse, Dependence, or Withdrawal Be Added to Dsm - IV and Icd - 10?
- 2046399651 54
- 2046399652-9660 Tobacco Withdrawal in Self - Quitters
- 2046399661 55
- 2046399662-9669 Symptoms of Tobacco Withdrawal A Replication and Extension
- 2046399670
- 2046399671-9763 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802 Volume 3.03 Effects of Abstinence From Tobacco A Critical Review
- 2046399764 57
- 2046399765-9769 Reports From Research Centres - 21 Human Behavioral Pharmacology Laboratory University of Vermont
- 2046399770 58
- 2046399771 Withdrawal Symptoms and Smoking Cessation
- 2046399772 59
- 2046399773-9778 Nicotine Vs Placebo Gum in General Medical Practice
- 2046399779 60
- 2046399780-9783 Prevalence of Tobacco Dependence and Withdrawal
- 2046399784 61
- 2046399785-9790 Signs and Symptoms of Tobacco Withdrawal
- 2046399791 62
- 2046399792-9798 Patterns and Predictors of Smoking Cessation Among Users of A Telephone Hotline
- 2046399799 63
- 2046399800-9820 Current Concepts of Addiction
- 2046399821 64
- 2046399822-9861 the American Academy of Psychiatrists in Alcoholism and Addictions 910000 Annual Meeting
- 2046399862 65
- 2046399863-9915 the Pharmacological Basis of Therapeutics Eighth Edition Chapter 22 Drug Addiction and Drug Abuse
- 2046399916 66
- 2046399917-9953 1 Tobacco Smoking and Nicotine Dependence
- 2046399954 67
- 2046399955-9957 Commentary Trivializing Dependence
- 2046399958 68
- 2046399959-9968 the Favorite Cigarette of the Day
- 2046399969 69
- 2046399970-9971 Overview: Alternative Forms of Pharmacologic Treatment
- 2046399972 70
- 2046399973-9974 British Medical Journal No 6891 Volume 306
- 2046399975 71
- 2046399976-9981 Original Contributors Predicting Smoking Cessation Who Will Quit with and Without the Nicotine Patch
- 2046399982 72
- 2046399983-0019 the Selling of Dsm the Rhetoric of Science in Psychiatry
- 2046400020 73
- 2046400021-0028 the Nosology of Abuse and Dependence
- 2046400029 74
- 2046400030-0035 Use and Misuse of the Concept of Craving by Alcohol, Tobacco, and Drug Researchers
- 2046400035A
- 2046400036-0045 Submission of Philip Morris Usa and the American Tobacco Company to the Drug Abuse Advisory Committee in Connection with Its Meeting on 940802
- 2046400046 75
- 2046400047-0048 What Researchers Make of What Cigarette Smokers Say: Filtering Smokers' Hot Air
- 2046400049 76
- 2046400050-0055 the Use of Flavor in Cigarette Substitutes
- 2046400056 77
- 2046400057-0060 Failure to Support the Validity of the Fagerstrom Tolerance Questionnaire As A Measure of Physiological Tolerance to Nicotine
- 2046400061 78
- 2046400062-0067 Effects of Cigarette Smoking on Electrodermal Orienting Reflexes to Stimulus Change and Stimulus Significance
- 2046400068 79
- 2046400069-0074 Behavioral (Non-Chemical) Addictions
- 2046400075 80
- 2046400076-0078 Nicotine Infused Into the Nucleus Accumbens Increases Synaptic Dopamine As Measured by in Vivo Microdialysis
- 2046400079 81
- 2046400080-0085 the Chemistry of Craving
- 2046400086 82
- 2046400087-0102 the Disease Controversy Revisited: An Ontologic Perspective
- 2046400103 83
- 2046400104-0134 A Psychopharmacological and Psychophysiological Evaluation of Smoking Motives
- 2046400135 84
- 2046400136-0146 Predictors and Reasons for Relapse in Smoking Cessation with Nicotine and Placebo Patches
- 2046400147 85
- 2046400148-0155 Clinical Trials and Therapeutics Nasal Spray Nicotine Replacement Suppresses Cigarette Smoking Desire and Behavior
- 2046400156 86
- 2046400157-0163 Predictors of Smoking Cessation in A Sample of Italian Smokers
- 2046400164 87
- 2046400165-0167 Clarification and Standardization of Substance Abuse Terminology
- 2046400168 88
- 2046400169-0179 the Role of Nicotine in Tobacco Use
- 2046400180 89
- 2046400181-0186 Pharmacoepidemiology and Drug Utilization How the Steady - State Cotinine Concentration in Cigarette Smokers Is Directly Related to Nicotine Intake
- 2046400187 90
- 2046400188-0192 Transdermal Nicotine As A Strategy for Nicotine Replacement
- 2046400193
- 2046400194-0198 Sensory Blockade of Smoking Satisfaction
- 2046400199 92
- 2046400200-0204 Brief Report Subjective Response to Cigarette Smoking Following Airway Anesthetization
- 2046400205 93
- 2046400206-0212 Intervention Strategies for Smoking Cessation the Role of Oncology Nursing
- 2046400213 94
- 2046400214-0219 Reduction of Tar, Nicotine and Carbon Monoxide Intake in Low Tar Smokers
- 2046400220 95
- 2046400221-0234 Long-Term Switching to Low-Tar Low-Nicotine Cigarettes
- 2046400235 96
- 2046400236-0239 Comment Recidivism and Self-Cure of Smoking and Obesity: An Attempt to Replicate
- 2046400240 97
- 2046400241-0249 Recidivism and Self-Cure of Smoking and Obesity
- 2046400250 98
- 2046400251-0263 Public Forum Love: Addiction or Road to Self-Realization, A Second Look
- 2046400264 99
- 2046400265-0274 Pharmacological and Non-Pharmacological Smoking Motives: A Replication and Extension
- 2046400275 100
- 2046400276-0289 Overcoming the Loss of A Love: Preventing Love Addiction and Promoting Positive Emotional Health
- 2046400290 101
- 2046400291-0298 the Health Benefits of Smoking Cessation A Report of the Surgeon General
- 2046400299 102
- 2046400300-0338 the Health Consequences of Smoking Nicotine Addiction A Report of the Surgeon General
- 2046400339 103
- 2046400340-0357 the Health Consequences of Smoking Chronic Obstructive Lung Disease A Report of the Surgeon General Chapter 6. Low Yield Cigarettes and Their Role in Chronic Obstructive Lung Disease
- 2046400358 104
- 2046400359 Smoking and Health Report of the Advisory Committee to the Surgeon General of the Public Health Service
- 2046400360-0369 Chapter 13 Characterization of the Tobacco Habit
- 2046400370 105
- 2046400371-0375 Is Nicotine Use An Addiction
- 2046400376 106
- 2046400377-0391 Nicotine Pharmacodynamics: Some Unresolved Issues
- 2046400392 107
- 2046400393-0400 Craving for Cigarettes
- 2046400401 108
- 2046400402 Smoker Motivation A Review of Contemporary Literature
- 2046400403-0453 Chapter 1 Trends in Cigarette Consumption and the Sociodemographic Structure of the Smoking Population in Developed Industrial Countries
- 2046400454 109
- 2046400455-0461 Increase of Circulating Beta-Endorphin-Like Immunoreactivity Correlates with the Change in Feeling of Pleasantness After Running
- 2046400462 110
- 2046400463-0469 New Data Note Series - 20 Severity of Dependence: Data From the Dsm-IV Field Trials
- 2046400470 111
- 2046400471-0479 World Health Organization Technical Report Series No. 551 Who Expert Committee on Drug Dependence Twentieth Report
- 2046400480 112
- 2046400481-0489 Cigarette Brand-Switching: Effects on Smoke Exposure and Smoking Behavior
- 2046400490
- Litigation
- Stmn/Produced
- Area
- WORLDWIDE REG AFFAIRS/LIBRARY
- Date Loaded
- 05 Jun 1998
- UCSF Legacy ID
- olj75e00
Document Images
.1
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
r
Kari-Olov Fagerstrom
Ufteroker Flospitol. Uppsda, Sweden
Tolerance, withdrawal and dependence
on tobacco and smoking termination
Introduction
This paper describes the development of a questionnaire for
measuring physical dependence on tobacco smoking. Data will be
reported on how the instrument was validated and how it relates to
phenomena such as smoking cessation, withdrawal symptoms and
regulation of nicotine intake. No attempt is made to disentangle or
differentiate between physical and psychological dependence. Con-
sequently when dependence in the pharmacological sense is used it
does not mean that psychological influences are totally ruled out.
Tobacco use in the form of cigarette smoking has been
widespread in industrialized countries since World War II. Despite
a decline in the proportions of smokers in many Western countries
during recent years, the sheer number of smokers remains high. In
the USA it is estimated that in 1980 32 per cent of the adult popula-
tion were smokers (US Dept HHS, 1981) and in Sweden in 1980 the
figure was 29 per cent (NTS, 1981). Today there is little doubt that
smoking represents a health risk. In a country the size of Sweden,
with only 8 million inhabitants, the estimated annual cost to society
is S250 million (US) (Jonsson, 1980). Estimate of the total annual
cost for the USA is approximately S18 billion (US) (Luce &
Schweitzer, 1977). Therefore it is hardly surprising that the WHO
(1975) concluded that the control of cigarette smoking could do
more to prolong life and improve health in industrialized countries
than any other single action in the entire field of preventive
medicine. Ongoing campaigns in many countries to eliminate or
late,national Review, oof Applied Psychology (SAGE. London. Beverly Hills and
New Deihi). Vol. 32k1983). 29-52
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
30 Karl-Olov FagtrstrfSm
reduce tobacco smoking are not producing striking results. Among
physicians, over 20 per cent continue to smoke despite their better
knowledge. An exception is the USA where the figure is around
5-10 per cent. The prospects of abolishing or at least strongly
diminishing tobacco use in the rest of the population through infor-
mation alone would seem remote. Difficulties encountered in in-
fluencing users of tobacco may be attributable to the addicting pro-
perties of the substance, the social acceptability of the habit and the
psychological needs fulfilled by smoking. The social acceptability
guarantees that, under normal conditions, smokers are not forced
into antisocial behaviors for maintaining their smoking as are for
example, narcotic addicts dependent upon morphine. However,
when the supply of tobacco is restricted as it was in Germany after
World War II, smokers engaged in extreme beh,aviors to satisfy
their need for tobacco. Despite conditions of extreme deprivation
and in situations where food rations were under 1000 calories per
day smokers still bartered edibles for cigarettes. The craving for
tobacco, was so overwhelming that individuals were willing to
engage in prostitution or larceny to procure goods to trade for
cigarettes (Blair, 1979).
Tobacco usage seems to flourish in societies which have been ex-
posed to it unless it is specifically prohibited for religious reasons.
The use of tobacco is readily adopted by cultures that are ignorant
of the health risks and without social pressure for or against smok-
ing (Damon, 1973). In 1974, 278 British opiate users were asked to
rank a number of drugs with respect to greatest personal need.
Cigarettes were rated above heroin, methadone, amphetamine,
barbiturates, LSD, cannabis, alcohol and tea or coffee (Russell,
1971). The same investigator concluded some years later that
'cigarette smoking is probably the most addictive and dependence
producing form of self-administered gratification known to man'
(Russell, 1974). Measuring abstinence rates from several treatment
programs for smokers and heroin addicts, Hunt, Barnett and
Branch (1971) found that the two groups had the same absolute and
relative relapse rate.
Smoking tobacco seems to meet the three criteria for addic;ion.
First, tolerance develops very rapidly, within hours and days,
whereafter it is relatively stable (Jones, Farrell & Herning, 1979).
Second, dependence on nicotine is readily observed on self-
administering rats (Hanson, Ivester & Morton, 1978) and more
familiarly by humans. Third, withdrawal symptoms upon disconti-

I
I
I
I
I
I
I
I
I
I
I
I
I
Tobacco dependence and smoking termination 31
nuing tobacco usage are common (Shiffman, 1979).
Clinical experience with individuals seeking help to stop smoking
indicates that dcgree of addiction varies greatly. Those seeking help
are probably more addicted, unable to quit on their own and thus
amenable to help from other sources. At one extreme, clinicians
find individuals who can abstain from tobacco for several days
without undue physical or mental discomfort. These individuals
often inhale rarely and smoke low nicotine brands. They vary the
time intervals between cigarettes considerably and have no difficul-
ty in refraining when smoking is not allowed. At one other extreme
are individuals who light a cigarette before they get out of bed, ex-
perience withdrawal symptoms when a limited time has passed bet-
ween cigarettes and chain smoke the first two or three cigarettes of
the day. These individuals can seldom sit through a performance or
meeting without leaving for a cigarette, operating on a relatively
fixed interval schedule and preferring high nicotine cigarettes.
Smokers differ not only in the behavior they exhibit but also in
the kinds of difficulties they encounter when they quit. The dif-
ferences depicted above are most readily conceptualized as dif-
ferences in tolerance and dependence on tobacco (more specifically
to nicotine).
Several researchers have tried to explain the differences in smok-
ing behavior among individuals. The two most well-known smok-
ing >'ypologies ba_sed on factor analysis of smoking related ques-
tionnaires are Tomkins' 'Reasons for Smoking' Questionnaire and
Russell's `Classification of Smoking by Motives' (Tomkins, 1966,
Ikard, Green and Horn, 1969 and Russell, 1974).
The factors found by Tomkins, Ikard, Green and Horn were
called smoking for (a) pleasurable relaxation, (b) reducing negative
affect, (c) stimulation, (d) sensorimotor manipulation, (e) habit,
and (f) addiction. Russell, Peto and Patel's typology uses six fac-
tors: (a) stimulation smoking, (b) indulgent smoking, (c) psycho-
logical smoking, (d) sensorimotor smoking, (e) addictive smoking
and (f) automatic smoking (Russell, 1974). Russell et al. (1975,
1976) emphasize the addiction component more than Tomkins and
his associates. Despite the fact that many investigators regard
tobacco smoking as addictive and dependence producing and that
clinicians are daily confronted with smokers' attempts to break the
habit, no systematic attempt has been made to develop a measure-
ment for nicotine dependence.
Such a measurement should be valuable in smoking cessation
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
32 Karl-Olov Fa;erstrOm
outcome research and nicotine regulation studies, since the concept
of dependence seems inherently related to both cessation outcome
and nicotine regulation. In both types of studies there is con-
siderable variation in outcome that is partly attributable to in-
dividual differences. With dependence under control, much of
what earlier has been termed error variance could perhaps be ex-
plained.
It is also assumed that a measure of pharmacological dependence
could be used as a diagnostic tool for choosing the most ap-
propriate treatment strategy for smoking cessation.
Me2surinQ degree of physical dependence on tobacco smokinR.
A basic assumption serves as a starting point for a discussion of
physical dependence: all regular smokers are addicred, whether it
be psychological or physiological addiction. All are probably
psychologically dependent upon cigarettes but some could also be
called true addicts in the physiological/medical sense of the term.
The two concepts are by no means simple to untangle since they
cannot be measured directly. per se.
What wou,u cnaractertzc a true cigarette/tobacco addict? It is
feasible to think that physical dependence has to do with:
(a) how often the drug is used (number of cigarettes/day)
(b) the strength of the dose (the level of nicotine delivery of the
brand)
(c) the effective utilization of the drug (e.g. through regulation of
inhalation)
(d) smoking immediately after awakening in the morning and at a
higher rate (because of nicotine's short half-life, the plasma
level is very low)
(e) rating the first cigarette in the morning as the best one (because
of its power to alleviate withdrawal symptoms)
(f) more internal stimulus control relative to external control,
manifesting itself in difficulties to refrain f*'om smoking where
it is prohibited e.g. in churches (as the blood nicotine level may
become too low).
From these six major assumptions eight questions, called the
Tolerance Questionnaire (Fagerstrom, 1978), were constructed.
1. How soon after you wake up do you smoke your first
cigarette?
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
Tobacco dependence and smoking termination 33
2. Do you find it difficult to refrain from smoking in places where
it is forbidden, e.g. in church, at the library etc?
3. Which of all the cigarettes you smoke in a day is the most satis-
fying?
4. How many cigarettes a day do you smoke?
5. Do you smoke more during the morning than during the rest of
the day?
6. Do you smoke if you are so ill that you are in bed most of the
day?
7. What brand do you smoke?
8. How often do you inhale?
The questions are scored so that higher scores indicate greater ad-
diction. For details of the scoring consult Fagerstrom, 1978. The
questionnaire has a range of 0-11 points with zero indicating
minimum physical dependence and eleven points maximum
physical dependence. The questions are ordered according to their
loadings in a factor analysis where the dependence factor was clear-
ly demonstrated. The first six questions had loadings in the factor
of at least 0.60.
Validation of the questionnaire
Withdrawal as change in body temperature
Validation of the questionnaire was first studied in relation to a
withdrawal response: body temperature. It was assumed that the
well-known changes in peripheral temperature as an effect of
smoking (e.g. Auge, 1973; Larson. Haag & Silvette, 1961) in some
way corresponds with internal body temperature. Body
temperature has also been found to be reacive in the initial stages
of abstinence to drugs such as opiates and barbiturates (Liaynert,
1968).
Method. To investigate whether temperature changes could be
related to degree of dependence as measured by the Tolerance
Questionnaire (TQ) twenty-six subjects seeking help at a smoking
withdrawal clinic were recruited. The TQ was mailed to the
smokers, to be filled in before the first visit to the clinic. Body
temperature was recorded within a week before and within two
days after complete smoking termination. Temperature was
measured orally during visits to the clinic. Variations due to time of
I

I
I
I
I
I
I
I
I
I
I
34 Karl-Otov FcRersrrom
day and menstrual cycle were taken into consideration.
Results. As an effect of smoking termination half of the twenty-
six smokers showed increase and the other half showed decrease in
body temperature. However, when the withdrawal response (defin-
ed as body temperature before and after smoking termination) was
calculated and correlated with the questionnaire, a correlation of
-0.55 (p<.01) was obtained. This negative relationship means
that the body temperature of the more physically dependent
smokers showed an increase.
Heart rate increase as acquired tolerance
In the second experiment within the same study, acquired tolerance
(Kalant, LeBlanc & Gibbins, 1971) among regular smokers was
employed as an indicator of physical dependence. Autonomic ac-
tivity operationalized as heart rate increase was used as the depen-
dent variable since many researchers have documented increases in
heart rate after the smoking of a cigarette (e.g. Herxheimer, Grif-
fiths, Hamilton & Wakefield, 1967).
Method. Nineteen regular smokers participated in this study.
The. subjects began the experiment by sitting in a chair while a
stable heart rate was established. For measuring heart ra,e a detec-
tor was attached to the subject's chest. Once heart rate was stable,
the smoker proceeded to smoke a cigarette with an interpuff inter-
val of 15 seconds. Observations were made to ensure that the sub-
jects inhaled and took puffs of approximately equal deFth. Heart
rate increase was defined as the peak heart rate value recorded sub-
tracted from the baseline heart rate.
Results. The correlation coefficient between heart and the TQ
score was -0.69 (p<.01), which means that the more physically
dependent smokers had a smaller increase in heart rate than the less
physically dependent smokers. The increase varied between 3 and
33 beats/min, the average increase being 15.2 beats/min. As in ex-
periment 1, the daily cigarette consumption can be a third variable
interfering with the above correlation. When the number of cigaret-
tes smoked per day was partialled out, a slight attenuation oi the
correlations in both experiments was found, however still within
the one per cent level of significance.
I

I
I
I
I
I
I
I
I
I
I
I
Tobacco dependence cnd smokinR termination 35
Discussion
The results cited above indicate that the TQ seems to measure
something which appears related to a genuine addiction with its
triad of tolerance, dependence and withdrawal. In the experiments,
tolerance and physical withdrawal were measured and found to
vary according to the answers to the eight smoking behavior ques-
tions.
Based on the two experiments described it seems that the TQ has
a certain validity for measuring physical dependence. The utility of
the questionnaire, however, remains to be demonstrated in predic-
ting withdrawal symptoms, accounting for variations in smoking
cessation outcome and, most essential, in treatment studies where
the effects of therapy components are evaluated separately for high
and low dependent subjects.
Physical withdrawal responses 2nd success in smoking cessation
In the next study concerning quitters' physical withdrawal
responses (Fagerstrbm, 1980) the likelihood of success in quitting
and reduction of the withdrawal responses with the help of a
nicotine substitute were studied in relation to physical dependence.
Physical wirhdrawal
The majority of smokers quit with minimal physical withdrawal.
symptoms. However, all experience some psychological changes,
-such as increased irritation, fluctuation in mood, aggressiveness,
increased anxiety, indifference, diminished stress tolerance and
craving for tobacco. In the study to be reported below, the aim was
to isolate the physical symptoms of tobacco withdrawal. The
distinction between physical and psychic responses is somewhat ar-
tificial and by no means simple to delineate. Most of the responses
recorded here are probably consequences of a drop in blood
pressure that often takes place during the first two we-Cks
(headache, dizziness, sweating, inability to concentrate). The other
symptoms recorded were constipation (probably due to the absence
of the gastrocolic reflex caused by cigarette smoking) and creeping
sensations in or beneath the skin (due to spasmodic relaYation of
I

I
t
I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
36 Xarl-Olov Fagersrr6m
the smooth musculature in the peripheral vessels). Two weeks after
quitting, ex-smokers were given a questionniare in which they were
asked to rate their abstinence responses. On each response they had
to choose an alternative from zero (not experienced at all) to three
(experienced very severly). When the total sum of these ratings was
calculated and correlated with their TQ score a positive correlation
of 0.40 (p<.01) was found, i.e. the more dependent the subject, the
more withdrawal responses s/he is likely to experience.
To ascertain whether these withdrawal symptoms were related to
absence of nicotine and consequently could be reduced by ad-
ministering nicotine, thirty smokers who wanted to quit were
given a supply of nicotine chewing gum (Nicorette,) and com-
pared with thirty smokers who received no nicotine substitute.
These two groups differed significantly (p<.05) in terms of
physical withdrawal symptoms. Those having access to the nicotine
substitute experienced fewer symptoms. There also seemed to be a
relationship between the quantity of nicotine gum chewed and
degree of physical withdrawal. The more gum consumed, the less
withdrawal symptoms recorded (p<.05). No placebo group was
compared with these smokers, so these findings can only be sug-
gestive.
Likelihood of success in quitting
The outcome of a smoking cessation attempt is influenced by a vast
number of factors, for example how does physical dependence on
tobacco smoking influence cessation? In order to investigate this
question 130 patients at the smoking cessation clinic were classified
as smokers or ex-smokers three months after quitting. The average
scores on the TQ for the successful and unsuccessful quitters were
6.2 and 7.0 (p<.05) respectively, which implies that the unsuc-
cessful subjects were more physically dependent than their suc-
cessful counterparts. This difference in outcome for smokers with
different degrees of dependence has been replicated many times at
the clinic, and usually with only 50-75 subjects needed to establish a
significant difference. The TQ thus sezm to be a good predictor of
outcome. Since the highly dependent smokers have a substantially
reduced probability of succeeding and since the common
abstinence rates at twelve months for most smoking cessation pro-
grams are as low as 20 per cent (Leventhal & Clearly, 1980) one
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
Tobacco dependence and smokinR terminarion 37
wonders how low the percentage abstinent is for the highly depen-
dent subjects.
Conclusions and implications
These results suggest that: (a) the degree of dependence determines
or at least covaries with the more physical withdrawal responses
that smokers may encounter, (b) nicotine is likely to be a crucial
factor in the etiology of the withdrawal responses, (c) nicotine in the
form of a chewing gum may be helpful in reducing the abstinence
responses, (d) unsuccessful quitters are more physically dependent
on cigarettes and probably require other intervention strategies
than less dependent smokers. Nicotine chewing gum could well be
such an intervention for smokers who then could quit with a two-
step program. The first steps aims at stopping the smoking and the
second step at gradually reducing the amount of nicotine used as
the strength of the smoking habit diminishes.
A placebo controlled evaluation of the effectiveness
of a nicotine gum in smoking cessation
In order to test the assumption above, i.e. that a nicotine substitute
in the form of a chewing gum could be a valuable aid in smoking
cessation, especially for highly dependent smokers, a double-blind
controlled study was carried out at the smoking cessation clinic
(Fagerstrdm, in press a).
Method
Subjects and design. One hundred consecutive patients from the
clinic's waiting list were randomly assigned to the experimental
(nicotine chewing gum and psychological treatment) or control
(placebo gum and psychological treatment) groups. Fifty-nine of
the one hundred smokers were women.
The patients were seen individually by the author and given in-
dividualized counseling, averaging 7.7 sessions per patient. The sub-
jects in both the nicotine and placebo gum groups were told that
they would have access to chewing gum containing nicotine, which
I

I
I
I
I
I
I
I
I
I
I
I
I
I
I
I
38 Kar!Olov Fogerstrom
TABLE 1
A comprehensive smoking cessation program
.4ssessment
Ten days recording of tar and nicotine intake
Medical check-up
Carbon monoxide concentrations pre- and post-cessation
Review of motives
Feedback to the medical motives, e.g. demonstration of decreased circulation
contingent on smoking
Recording of weight
Treatment components
General medical and health informauon
Nonspecific support, encouragement and reinforcement ~
Warm accepting atmosphere
Patient decides quitting day
Education in self-control techniques
Administration of chewing gum (nicotine and placebo)
Sensitization of how smokers relapse
Personal contact 4-6 months with 6-l5 sessions
After 6 months post cards should be mailed to the clinic
Opportunity to smoke at the clinic whenever desired
Ocrarionally used components
Rapid and aversive smoking
Stimulus control
Rardy used components
Hypnosis
Relaxation
Covert sensitization
Contracting
Furtdamental premrses
Complete absttnence should be reached at least withtn 20 days
Highly nicotine dependent subjects cannot take occasional cigarette
Gradual reduction is not a serious alternative to 'coid turkey'
High deyree of individualizatton
would be administered from the first session. The double-blind
code was broken by the author when the subject had ceased to use
the chewing gum, never earlier than three months after the in-
dividual stopped smoking.
Treatment. In addition to the placebo or nicotine gum, patients
also took part in a comprehensive psychological smoking cessation
